CYP19A1 and Gynecomastia: Three possible categories of drugs have been considered for the treatment of pathologic gynecomastia: (1) selective estrogen receptor modulators such as tamoxifen, raloxifene, and clomiphene citrate; (2) aromatase inhibitors such as testolactone, anastrozole, and letrozole; and (3) androgens.